3 Day MBA in Vaccines

Who will benefit

  • Pharmaceutical companies
  • CROs
  • CMOs
  • Lawyers
  • Suppliers
  • Government and regulators
  • Consultants
  • Investors
  • Banks

Who's attending

  • C-Level Executives: CEO, CFO, COO
  • Business Development and Sales
  • Marketing and Public Relations
  • Human Resources
  • Investor Relations
  • Strategic Planning
  • Lawyers
  • Procurement and
  • Sourcing
  • Research and Development

Get to grips with the vaccines industry in just three days with the 3 Day MBA in Vaccines

At the 3 Day MBA in Vaccines, you'll explore all the critical issues and challenges in the global vaccines industry. At the end of the three days, you’ll be able to better position your organisation to compete effectively in today’s fast changing environment.

The 3 Day MBA in Vaccines is an introductory-level course designed to bridge knowledge gaps and give you true business advantage. It is most useful to new entrants, senior managers needing a big picture refresher and professional advisors and suppliers.

You’ll gain an insight into current issues, industry terminology, operational challenges, legal and regulatory requirements and vaccines in the market place. These valuable insights will help you to be the first to identify and exploit opportunities while your competitors are still doing their research.

In just three days you will:

  • Analyse the world vaccines market
  • Understand the science of vaccines
  • Navigate legal issues and the role of the government
  • Learn about research and development in the vaccines industry
  • Understand how vaccines are manufactured, promoted and distributed
  • Review threats to the value of the industry
  • Consider the importance of social responsibility in a commercial world
  • Discover what new technologies are emerging and the future of the industry


Don't take our word for it!

Read what past delegates have to say about the course

"Basically the precise curriculum I was looking for"
Program Officer, The Bill & Melinda Gates Foundation

"The trainer is well experienced, and able to talk generally about the topics and share personal stories - three inspiring days"
Specialist, Emergent BioSolutions 

"Kevin is clearly an expert and a pleasure to learn from, superior choice of teacher/professor" 
Employee of Agency for Electronic Communications

3 Day MBA in Vaccines
a short overview

choose how to take the course:

Scheduled courses

Scheduled courses

Our short face-to-face courses run throughout the year, across the globe

21-23 May 2014
26-28 May 2014
Washington D.C.
9-11 June 2014
Hong Kong
10-12 November 2014
24-26 November 2014
Washington D.C.
10-12 December 2014

Agenda overview

Day 1: The vaccines industry: an introduction

History of vaccines and an overview of terminology

Get an introduction to the science of vaccines, understand the different types of vaccines and types of administration.

The world market for vaccines

Look at how the market has evolved and what the predictions are for the future.

Key commercial players

Look at the "big five" of the vaccines market and understand the difference between their strategies.

The role of government

Understand who the main decision-makers are and appreciate the impact of patient groups (good and bad).

Day 2: Researching and developing vaccines

Research and development
Learn about the sources of products, preclinical testing, phases of clinical development and the impact of scale up challenges.

Manufacturing and distribution
Discover the principles of manufacturing, wholesale distribution and retail distribution.

Learn about compensation schemes, patient information and governmental contracts.

Social responsibility
Explore how the industry can balance world health with shareholder return.

Day 3: Global threats, evolving markets and the future of vaccines

Industry threats and the value of vaccines
Understand the industry response to pandemic influenza and review the times when things have gone wrong and what we have learnt.

Evolving markets
Discover the evolving markets in Japan, India, China and the Third World.

New technologies
Explore new technologies from DNA approaches and adjuvants to delivery systems and mucosal vaccines.

The next ten years
Review what the future holds for the vaccines industry and discover the unmet needs still outstanding.